Clinical Trial Update: A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. [Phase 1]

View source ↗

Summary

Phase I pharmacokinetic study of nevirapine extended-release (XR) in HIV-1 infected children. The trial has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Nevirapine XR (extended-release) (nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2014-05-07